- ►nejm.org [PDF] PM Ridker, NR Cook, I Lee… - New England Journal of Medicine, 2005 - content.nejm.org From the Divisions of Preventive Medicine (P.MR., NRC, IM.L., DG, JMG, JEM,
JEB), Cardiovascular Medicine (P.MR., JMG), and Aging (JMG, JEB), Depart- ment
of Medicine, Brigham and Women's Hospital, Harvard Medical School; the De- ... Cited by 897 - Related articles - BL Direct - All 49 versions
- ►nih.gov [PDF] GJ Hankey, JW Eikelboom - The Lancet, 2006 - Elsevier Aspirin resistance is the inability of aspirin to reduce platelet production of
thromboxane A 2 and thereby platelet activation and aggregation. Increasing
degrees of aspirin resistance may correlate independently with increasing ... Cited by 290 - Related articles - BL Direct - All 20 versions
T Cuisset, C Frere, J Quilici, F Barbou, PE … - Journal of Thrombosis and Haemostasis, 2006 - interscience.wiley.com Summary. Background and objectives: Low response to antiplatelet therapy may be
a risk factor for the development of ischemic complications in patients with
non-ST segment elevation acute coronary syndrome (NSTE ACS) undergoing ... Cited by 151 - Related articles - BL Direct - All 3 versions
- ►spectracell.com [PDF] JD Snoep, M Hovens, JCJ Eikenboom, JG … - Archives of Internal Medicine, 2007 - archinte.highwire.org Background The risk of recurrence of cardiovascular events among patients using
aspirin (acetylsalicylic acid) for secondary prevention of such events remains
high. Persistent platelet reactivity despite aspirin therapy, a laboratory- ... Cited by 101 - Related articles - BL Direct - All 7 versions
KR McQuaid, L Laine - The American journal of medicine, 2006 - Elsevier Aspirin increased the risk of major bleeding (RR = 1.71; 95% confidence interval
[CI], 1.41-2.08), major gastrointestinal (GI) bleeding (RR = 2.07; 95% CI,
1.61-2.66), and intracranial bleeding (RR = 1.65; 95% CI, 1.06-5.99) versus ... Cited by 90 - Related articles - All 27 versions
MMC Hovens, JD Snoep, JCJ Eikenboom, JG … - American Heart Journal, 2007 - Elsevier We included 34 full-text articles and 8 meeting abstracts. The mean prevalence
of aspirin resistance was 24% (95% CI 20%-28%). After adjustment for differences
in definition, used dosage, and population, a statistically significant ... Cited by 85 - Related articles - All 11 versions
- ►hematologylibrary.org [PDF] T Murase, M Yamaguchi, R Suzuki, M Okamoto, … - Blood, 2006 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 55 - Related articles - BL Direct - All 4 versions
A Szczeklik, J Musial, A Undas, M Sanak, R … - Pharmacological Reports, 2005 - if-pan.krakow.pl Abstract: Aspirin protects many though not all patients from acute
cardiovascular events. It is generally accepted that such prophylactic effect
depends mainly on the antithrombotic action involving inhibition of ... Cited by 57 - Related articles - View as HTML - BL Direct - All 15 versions
P Fontana, S Nolli, G Reber, P De Moerloose - Journal of Thrombosis and Haemostasis, 2006 - interscience.wiley.com Summary. Background: Some data suggest that biological 'resistance' to aspirin
or clopidogrel may influence clinical outcome. Objective: The aim of this study
was to evaluate the relationship between aspirin and clopidogrel ... Cited by 48 - Related articles - BL Direct - All 3 versions
HA Tran, SS Anand, GJ Hankey, JW … - Thrombosis research, 2007 - Elsevier Aspirin resistance refers to less than expected suppression of thromboxane A 2
production by aspirin and has been reported to be independently associated with
an increased risk of adverse cardiovascular events. Possible causes of ... Cited by 35 - Related articles - All 11 versions
